Benzamide modulators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2004226450 (hide)

Owner Merck & Co. Inc.

Inventors Duggan, Mark E.; Wisnoski, David D.; Lindsley, Craig W.

Agent Spruson & Ferguson

Pub. Number AU-A-2004226450

PCT Pub. Number WO2004/087048

Priority 60/457,734 26.03.03 US

Filing date 22 March 2004

Wipo publication date 14 October 2004

International Classifications

C07D 209/34 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087048 Priority application(s): WO2004/087048

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226452-Bicyclic piperidine derivatives as melanocortin-4 receptor agonists

2004226443-Confectionery with fast flavor release jacket coating